சர்வதேச ஐசோடோப்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சர்வதேச ஐசோடோப்புகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சர்வதேச ஐசோடோப்புகள் Today - Breaking & Trending Today

Therapeutic Nuclear Medicines Market – Global Business Dynamics, Industry Opportunities, Risk And Dr


Search jobs
25-May-2021
Therapeutic Nuclear Medicines Market – Global Business Dynamics, Industry Opportunities, Risk And Driving Force 2028 | Bayer AG, Novartis AG, GE Healthcare, Curium Pharmaceuticals & so on…
According to a new market study by Future Market Insights (FMI), the global therapeutic nuclear medicines market will expand at a healthy rate between 2018 and 2028.
The growth of the market is majorly attributed to factors such as the growing acceptance rate of therapeutic nuclear medicines, also known as radiopharmaceuticals, among consumers and medical professionals. These medicines have proven to be largely free of negative side-effects and minimal risk factors.
Furthermore, the rising prevalence of prostate cancer is acting as a major growth attribute to the market. As the per statistics of the U.K. cancer research organization, prostate cancer is the most prevalent cancer among men with over 47 ....

United States , Asia Pacific , Eckert Ziegler , Bayer Ag , Progenics Pharmaceuticals Inc , Spectrum Pharmaceuticals , Curium Pharmaceuticals , Drugs Administration , Lantheus Medical Imaging Inc , Therapeutic Nuclear Medicines Market , International Isotopes Inc , American Cancer Society , Ge Healthcare , Future Market Insights , Nuclear Medicines Market , Queries Linked , Western Europe , Latin America , Middle East , Jubilant Draximage , Progenics Pharmaceuticals , Lantheus Medical Imaging , International Isotopes , Research Approach , ஒன்றுபட்டது மாநிலங்களில் , ஆசியா பெஸிஃபிக் ,

International Isotopes Inc. Provides An Update On Recent Business Events


Share this article
Share this article
IDAHO FALLS, Idaho, Jan. 26, 2021 /PRNewswire/  International Isotopes Inc. (OTCQB: INIS) (the Company ) is pleased to announce the following developments.
International Isotopes recently signed a distribution agreement with a large American healthcare  services company for its I-131 drug product for the treatment of disease of the thyroid and thyroid cancer.  INIS expects to start distributing product to this company later in the first quarter and this should help to further expand sales of this important product in the U.S..
The Company was recently notified by the Department of Energy that it has been indemnified under the Price Anderson Act for a release of Cesium that occurred in May of 2019.  The Company s field services unit, which has since been discontinued as the Company has focused on growing its healthcare related business segments, was removing an expended Cesium source from a blood irradiator unit, when the ....

United States , Department Of Energy , District Of Columbia , Idaho Falls , David Drewitz , Company Board Of Directors , International Isotopes , Exchange Commission , International Isotopes Inc , Securities Exchange , Washington Department Of Health , Creative Options Communications , Nuclear Regulatory Commission , Price Anderson Act , Washington Department , Securities Act , Securities Exchange Act , Annual Report , ஒன்றுபட்டது மாநிலங்களில் , துறை ஆஃப் ஆற்றல் , மாவட்டம் ஆஃப் கொலம்பியா , ஐடஹோ விழும் , நிறுவனம் பலகை ஆஃப் இயக்குநர்கள் , சர்வதேச ஐசோடோப்புகள் , பரிமாற்றம் தரகு , சர்வதேச ஐசோடோப்புகள் இன்க் ,